88 Molecular basis of breast cancer Flashcards

1
Q

What % of all cancer is breast cancer?

A

~ 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What proportion of breast cancers is familial?

A

5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which 2 main genes defects predispose to breast cancer?

A

BRCA1 and BRCA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

BRCA1 gene defect, predisposes to which cancers?

A

Breast and ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the BRCA1 gene defect?

A
  • Autosomal dominant
  • Increases lifetime risk of breast cancer to 50-80%
  • Not completely penetrant
  • Increases ovarian risk to 40-50%
  • 1863 amino acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How to test for BRCA1 gene defect?

A

Sequencing
• Mutations occur throughout gene
• >650 different mutations identified
• Most result in truncated protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why do defects in BRCA1 predispose to cancer?

A

Two-hit hypothesis:
Both copies of tumour suppressor gene disrupted in tumour. Either:
1. May arise in both copies of the gene in the same cell by chance (rare and sporadic)
OR
2. Patient has inherited one defective copy of the gene already. In this situation only need one further mutation to occur by chance and tumour will arise.
Inheritance of the mutation therefore predisposes to disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of BRCA1?

A

In the DNA damage response. Relocalises to the site of damage, therefore acting as a caretaker instead of a gatekeeper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BRCA2 gene defects?

A
  • Increase risk of prostate cancer in males and breast cancer in females
  • Is a larger gene so more likely to have variants of unknown significance such as: Missense, intronic and small in frame deletions/insertions
  • > 400 mutations reported
  • Most result in truncated protein
  • Founder effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does BRCA2 do?

A

i dont know

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BRCA2 deficient cells are sensitive to…

A

DNA damaging agents:

• Cells from Tr/Tr mice are more sensitive to DNA damaging agents where damage has to be repaired via DNA DS repair pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the process of DNA double strand breaks?

A

Homology directed repair of DNA double strand breaks:

  • Structure unwound to reveal SS section
  • Then there is a cofrmation of D-loop structure
  • Where damaged DNA becomes intercalated with undamaged DNA of replicated chromosome (during S phase, i.e. doubling)
  • Intercalated produces repair template which restores wild type helix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Role of BRCA2 and DNA damage response?

A
  1. BRCA2 recruits Rad51 to sites of DNA damage
  2. BRCA2 promotes nucleation of the Rad51 filament
  3. BRCA2 stimulates Rad51-mediated strand exchange with D-loop formation

D-loop formation is the initial stage when the damage strand and template are brought together. Key in DNA DS break repairs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does breast cancer evolve from BRCA1/2 gene defects instead of other sites?

A
  • Tissue specific effects that promote tumourigenesis
  • Tissue specific expression of BRCA genes
  • Responsiveness to hormones, especially oestrogen
  • Bi-allelic loss of BRCA usually detrimental (chromosome instability)
  • Must be compensating mutations that allows BRCA-/- cells to grow out and evolve into full blown tumours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Other gene defects linked to breast cancer?

A
BRCA1
BRCA2
TP53
PTEN
ATM
CHEK2
BRIP1
PALB2
79 common SNPs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factors to consider in referral for genetic counselling?

A
  • Number of family members affected
  • What generations?
  • Age of onset
  • Ethnic background
  • Breast cancer susceptibility genes have low penetrance
  • Polygenic disease?
17
Q

Process of screening for breast cancer?

A

Screening= MRI detected 2X tumours than mammography, BUT high false +rate 11% cf 5% with mammography

18
Q

Options to manage risk of breast cancer

A

Mastectomy
Oophorectomy
Tamoxifen
Oral contraceptives

19
Q

What are implications for treatment?

A
  • DNA damaging agents
  • DNA Double strand breaks
  • Replication fork stalling
20
Q

What is synthetic lethality?

A

When two genetic mutations are independently compatible with life
BUT together cause mortality

Can be used in cancer treatment to selectively kill cancer cells which already have a gene mutation in one pathway

21
Q

Role of PARP (Poly ADP-Ribose Polymerase)?

A

Repairs SS DNA breaks by base excision repair (BER) were bases are damaged (as opposed to mismatched)

22
Q

Two pathways for DNA repair?

A

Homologous recombination pathway (relies on BRCA gene)
Base excision repair (relies on PARP)

Need at least 1 on order to repair DNA damage

23
Q

What can lead to DNA damage with SS break?

A
  • Oxygen radicals
  • Spontaneous reactions
  • X-rays
  • Alkylating agents
24
Q

How do cancer cells develop resistance?

A

One problem is resistance. CAPAN-1 cells have defective BRCA. Initially sensitive but become resistant over time ie cell lines PIR . Metaphase spreads left CAPAN-1 genetically unstable, Right PIR line, genetically stable

Reverse mutations – Diagram shows schematic of BRCA2 protein produced by the relevant cells- remember the rest of the gene is present even if the protein is truncated. BRCA-/- cells are deficient at DNA repair BUT can still do some albeit badly. Sometimes that repair results in a BRCA2 gene which has more function than the original cells so become resistant to drug

25
Q

Clues for sporadic breast cancer?

A
  • Early menarche
  • Late menopause
  • First child > 30 years of age
26
Q

What is the origin for breast cancer?

A

?

27
Q

How prevalent are oestrogen receptor (ER) positive tumours in the breast?

A

~ 60% of tumours ER Positive

28
Q

Mechanism of oestrogen positive tumours?

A

?

29
Q

What hormone therapy is available for breast cancer?

A

Tamoxifen

30
Q

What is tamoxifen?

A
  • Prodrug
  • Antagonist of Oestrogen receptor
  • Prevents expression of genes which would otherwise be stimulated by oestrogen
  • Often used prophylactically after surgery for early stage breast cancer
  • Common side effect- hot flushes
31
Q

Prevalence of Epidermal growth factor receptor 2 (HER2/ erbB2) positive breast cancers?

A
  • HER2/erbB2 over-expressed in 20-30% of tumours

* Gene amplification

32
Q

What does HER2/ erbB2 do?

A

?

33
Q

Action of trastuzimab (Herceptin)?

A
  • ‘Humanised’ monoclonal antibody to HER2
  • Prevents signalling
  • Suppresses growth and angiogenesis
  • Cell mediated cytotoxicity
  • Herceptin attaches to a HER2 cancer cell and tells body’s defence system to target the HER2 cancer
  • Herceptin may also stop the HER2 cancer from telling itself to grow and divide into more cancer cells
34
Q

Role of docetaxel in treating breast cancer?

A

Stabilises microtubules

35
Q

Mitotic catastrophe?

A
  • Stabilises microtubules
  • Aberrant, multipolar spindles
  • Chromosomes cannot segregate
  • Apoptosis